HIF1A and cancer: The clinical significance of HIF-1α and Beclin1 in OSCC patients was evaluated by analyzing the expression level of HIF-1α and Beclin1 in 80 OSCC tissues and pare-cancer tissue (tumor margin adjacent normal tissues) by the scoring of IHC (Fig. 1).